Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Calif. Prop 61 Raises Industry Concerns Over Ripple Effect

Executive Summary

Industry executives are speaking out against the measure that would require California state agencies to pay no more than the US Department of Veterans Affairs pay for drugs.

Advertisement

Related Content

Expect Industry To Step Up Drug Pricing Self-Regulation In 2017 – PwC
California’s Prop 61 Fails, But More Pricing Measures Could Be Ahead
California’s Prop 61 Fails, But More Pricing Measures Could Be Ahead
President Trump And Drug Pricing: What To Expect
President Trump And Drug Pricing: What To Expect
Industry Sounds Somewhat Muted Drug Pricing Alarm

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS119443

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel